AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34156730 — intervention group
Group type: COMPARATOR
Intervention: Control (5 Hz and 15 Hz)
Number of subjects: 33
Study 32761638 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week daily reminders
Number of subjects: 78
Study 32761638 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 78
Study 35357866 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-session parenting program
Number of subjects: 387
Study 35357866 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 387
Study 36057149 — intervention group
Group type: EXPERIMENTAL
Intervention: Scenario simulations of acute and critical care
Number of subjects: 88
Study 33162795 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief advisory session plus measuring exhaled CO
Number of subjects: 122
Study 33162795 — intervention group
Group type: COMPARATOR
Intervention: Brief advisory session (control)
Number of subjects: 122
Study 32624013 — intervention group
Group type: EXPERIMENTAL
Intervention: HeadGear smartphone app (30-day behavioural activation and mindfulness intervention)
Number of subjects: 2271
Study 32624013 — intervention group
Group type: COMPARATOR
Intervention: Attention-control app (30-day mood monitoring component)
Number of subjects: 2271
Study 33795571 — intervention group
Group type: EXPERIMENTAL
Intervention: HU-014
Number of subjects: 290
Study 33795571 — intervention group
Group type: COMPARATOR
Intervention: OnabotulinumtoxinA
Number of subjects: 290
Study 32785233 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet during Lenten fasting
Number of subjects: 75
Study 32785233 — intervention group
Group type: COMPARATOR
Intervention: Post-Lenten omnivore diet
Number of subjects: 75
Study 32785233 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegan diet in females
Number of subjects: 75
Study 36416980 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025% tretinoin cream
Number of subjects: 0
Study 36416980 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream
Number of subjects: 0
Study 33300952 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA test (Afirma genomic sequencing classifier)
Number of subjects: 346
Study 33300952 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA-RNA test (ThyroSeq v3 multigene genomic classifier)
Number of subjects: 346
Study 33300952 — intervention group
Group type: COMPARATOR
Intervention: RNA test (Afirma gene expression classifier)
Number of subjects: 346
Study 33300952 — intervention group
Group type: COMPARATOR
Intervention: DNA-RNA test (ThyroSeq v2 next-generation sequencing)
Number of subjects: 346
Study 33300952 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance ultrasonography
Number of subjects: 346
Study 35861823 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 107
Study 35861823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 34544403 — intervention group
Group type: EXPERIMENTAL
Intervention: IMARA program
Number of subjects: 525
Study 34544403 — intervention group
Group type: COMPARATOR
Intervention: Family-based control program
Number of subjects: 525
Study 33341312 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (1 mcg/day)
Number of subjects: 54
Study 33341312 — intervention group
Group type: COMPARATOR
Intervention: Cholecalciferol (50,000 IU/week)
Number of subjects: 54
Study 32792167 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic agents for human therapy in patients with COVID-19
Number of subjects: 60
Study 32792167 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of available drugs and prospective therapies
Number of subjects: 60
Study 35571615 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused psychological intervention combined with standardized pain nursing
Number of subjects: 84
Study 35571615 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 84
Study 34689451 — intervention group
Group type: EXPERIMENTAL
Intervention: Carica papaya mouthrinse
Number of subjects: 40
Study 34689451 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine (0.12%)
Number of subjects: 40
Study 34689451 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 40
Study 32776831 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical workers
Number of subjects: 40
Study 32776831 — intervention group
Group type: COMPARATOR
Intervention: Non-pharmaceutical subjects
Number of subjects: 40
Study 35275213 — intervention group
Group type: EXPERIMENTAL
Intervention: Hannay model
Number of subjects: 29
Study 35275213 — intervention group
Group type: COMPARATOR
Intervention: Sleep/wake parameters
Number of subjects: 29
Study 35275213 — intervention group
Group type: COMPARATOR
Intervention: Sleep/wake variables
Number of subjects: 29
Study 33479499 — intervention group
Group type: EXPERIMENTAL
Intervention: minimally processed, plant-based, low-fat diet (10.3% fat, 75.2% carbohydrate)
Number of subjects: 20
Study 33479499 — intervention group
Group type: COMPARATOR
Intervention: minimally processed, animal-based, ketogenic, low-carbohydrate diet (75.8% fat, 10.0% carbohydrate)
Number of subjects: 20
Study 34096413 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose intravenous alteplase
Number of subjects: 940
Study 34096413 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose intravenous alteplase
Number of subjects: 940
Study 34096413 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 940
Study 34096413 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure lowering
Number of subjects: 940
Study 34988183 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation (ONS) 300 mL/day for 4 weeks
Number of subjects: 77
Study 34988183 — intervention group
Group type: COMPARATOR
Intervention: Standard diet
Number of subjects: 77
Study 35589905 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Decision Aids (PDA)
Number of subjects: 151
Study 35589905 — intervention group
Group type: COMPARATOR
Intervention: Standard (SDM without PDA)
Number of subjects: 151
Study 33278332 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐NMB, sugammadex 2 mg/kg ABW
Number of subjects: 5
Study 33278332 — intervention group
Group type: EXPERIMENTAL
Intervention: M‐NMB, sugammadex 2 mg/kg IBW
Number of subjects: 5
Study 33278332 — intervention group
Group type: COMPARATOR
Intervention: M‐NMB, neostigmine 5 mg + glycopyrrolate 1 mg
Number of subjects: 5
Study 33278332 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐NMB, sugammadex 4 mg/kg ABW
Number of subjects: 5
Study 33278332 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐NMB, sugammadex 4 mg/kg IBW
Number of subjects: 5
Study 35938345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (IV)
Number of subjects: 50
Study 35938345 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia (LA)
Number of subjects: 50
Study 33512910 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) and targeted therapy
Number of subjects: 60
Study 33512910 — intervention group
Group type: COMPARATOR
Intervention: Targeted therapy alone
Number of subjects: 60
Study 32580978 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic therapy plus propranolol
Number of subjects: 40
Study 32580978 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic therapy plus propranolol
Number of subjects: 40
Study 36052527 — intervention group
Group type: EXPERIMENTAL
Intervention: 60-day head-down bed rest (HDBR)
Number of subjects: 20
Study 34490103 — intervention group
Group type: EXPERIMENTAL
Intervention: Adversarial deep-learning-based auto-segmentation model
Number of subjects: 20
Study 34490103 — intervention group
Group type: COMPARATOR
Intervention: Manual delineation by oncologists (GT)
Number of subjects: 20
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: DX1 (dexamethasone 24 mg + placebo)
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: DX2 (dexamethasone 24 mg + dexamethasone 24 mg)
Number of subjects: 485
Study 34983775 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo + placebo)
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: DX1 vs Placebo
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: DX2 vs Placebo
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: DX1 vs DX2
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (one dose)
Number of subjects: 485
Study 34983775 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (two doses)
Number of subjects: 485
Study 32059579 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency resistance training (3 times a week)
Number of subjects: 42
Study 32059579 — intervention group
Group type: COMPARATOR
Intervention: Low frequency resistance training (1 time a week)
Number of subjects: 42
Study 34637494 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K1 supplementation (10 mg/d)
Number of subjects: 149
Study 34637494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 34615722 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline adjuvant chemotherapy in basal breast cancer patients
Number of subjects: 819
Study 34615722 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen in basal breast cancer patients
Number of subjects: 819
Study 33341833 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental ney music played in the modal rhythm of Segah (Group A)
Number of subjects: 30
Study 33341833 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group B)
Number of subjects: 30
Study 36215044 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone (Control)
Number of subjects: 202
Study 34280784 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid anaesthesia (SA)
Number of subjects: 138
Study 34280784 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 138
Study 33882531 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated mental health and acute care clinical model on a dedicated education unit (DEU)
Number of subjects: 0
Study 33882531 — intervention group
Group type: COMPARATOR
Intervention: Traditional experience on an acute care and inpatient behavioral health unit
Number of subjects: 0
Study 32998098 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt stress treatment (low, medium, high)
Number of subjects: 0
Study 32998098 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene ontology analysis
Number of subjects: 0
Study 32998098 — intervention group
Group type: EXPERIMENTAL
Intervention: KEGG pathway annotation
Number of subjects: 0
Study 32998098 — intervention group
Group type: EXPERIMENTAL
Intervention: qRT-PCR analysis
Number of subjects: 0
Study 32359068 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention group (IMP)
Number of subjects: 95
Study 32359068 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced implementation intention group (IMP+)
Number of subjects: 95
Study 32359068 — intervention group
Group type: COMPARATOR
Intervention: Control goal intention group (GOL)
Number of subjects: 95
Study 32359068 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (IMP, IMP+, GOL)
Number of subjects: 95
Study 33126334 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion Style Acupuncture Treatment (MSAT)
Number of subjects: 128
Study 33126334 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture Treatment
Number of subjects: 128
Study 36120765 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy instrument mobilization (PIM)
Number of subjects: 32
Study 36120765 — intervention group
Group type: COMPARATOR
Intervention: Manual mobilization
Number of subjects: 32
Study 34425156 — intervention group
Group type: COMPARATOR
Intervention: Low initial oxygen concentration (≤30%)
Number of subjects: 720
Study 34425156 — intervention group
Group type: COMPARATOR
Intervention: High initial oxygen concentration (≥60%)
Number of subjects: 720
Study 34425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged bradycardia (HR <100 bpm for ≥2 min)
Number of subjects: 720
Study 34425156 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged bradycardia and SpO2 <80% at 5 min after birth
Number of subjects: 720
Study 34289338 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab 0.5 or 2.0 mg (all treatment arms pooled)
Number of subjects: 917
Study 34335043 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy combined with static magnetic field (PBMT-sMF)
Number of subjects: 30
Study 34335043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 35266003 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided management (treatment)
Number of subjects: 0
Study 35266003 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34915762 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin microdosing
Number of subjects: 0
Study 34915762 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35392354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Ketamine (0.5 mg/kg)
Number of subjects: 150
Study 35392354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal Meperidine (0.2 mg/kg)
Number of subjects: 150
Study 35392354 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Normal Saline (placebo)
Number of subjects: 150
Study 32664375 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength program
Number of subjects: 316
Study 32664375 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqua fitness program
Number of subjects: 316
Study 32664375 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic program
Number of subjects: 316
Study 35364722 — intervention group
Group type: EXPERIMENTAL
Intervention: 1540nm non-ablative fractional laser (NAFL) combined with silicones treatment
Number of subjects: 70
Study 35364722 — intervention group
Group type: COMPARATOR
Intervention: Silicones alone treatment
Number of subjects: 70
Study 34108518 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI/bevacizumab
Number of subjects: 486
Study 36176051 — intervention group
Group type: COMPARATOR
Intervention: Vutiglabridin (30-720 mg single dose)
Number of subjects: 0
Study 36176051 — intervention group
Group type: COMPARATOR
Intervention: Vutiglabridin (240-480 mg once daily for 14 days)
Number of subjects: 0
Study 36176051 — intervention group
Group type: COMPARATOR
Intervention: Vutiglabridin (240 mg single dose) with food effect evaluation
Number of subjects: 0
Study 36176051 — intervention group
Group type: EXPERIMENTAL
Intervention: Vutiglabridin (multiple doses)
Number of subjects: 0
Study 36176051 — intervention group
Group type: EXPERIMENTAL
Intervention: Vutiglabridin (MAD study)
Number of subjects: 0
Study 36176051 — intervention group
Group type: EXPERIMENTAL
Intervention: Vutiglabridin (general findings)
Number of subjects: 0
Study 33210938 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI; 412 h, $4,373 per participant)
Number of subjects: 218
Study 33210938 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity (LI; 24 h, $97 per participant)
Number of subjects: 218
Study 35726493 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task
Number of subjects: 90
Study 35726493 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-back task
Number of subjects: 90
Study 35726493 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 90
Study 34474622 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT) applied to paraspinal muscles
Number of subjects: 32
Study 34474622 — intervention group
Group type: COMPARATOR
Intervention: Neuro‐Developmental Treatment (NDT) programs
Number of subjects: 32
Study 35573718 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Number of subjects: 76
Study 35573718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 32331056 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM5
Number of subjects: 1693
Study 32331056 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM10
Number of subjects: 1693
Study 32331056 — intervention group
Group type: COMPARATOR
Intervention: PBO
Number of subjects: 1693
Study 34849659 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischaemic postconditioning (IPost)
Number of subjects: 209
Study 34849659 — intervention group
Group type: COMPARATOR
Intervention: Standard operation (Control)
Number of subjects: 209
Study 36072410 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with 50 mg diclofenac sodium (DS) sustained-release capsules once a day, treated three times in 7 days.
Number of subjects: 0
Study 36072410 — intervention group
Group type: COMPARATOR
Intervention: Low-dose diclofenac sodium (50 mg DS sustained-release capsules once a day).
Number of subjects: 0
Study 36072410 — intervention group
Group type: COMPARATOR
Intervention: Conventional-dose diclofenac sodium (100 mg DS sustained-release capsules once a day).
Number of subjects: 0
Study 32282572 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stabilization training robot (3DBT‐33) in addition to conventional physical therapy (30 min)
Number of subjects: 38
Study 32282572 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy
Number of subjects: 38
Study 35639696 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual drum tuition (two lessons per week over an 8‐wk period)
Number of subjects: 36
Study 35639696 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drum tuition)
Number of subjects: 36
Study 35639696 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual drum tuition
Number of subjects: 36
Study 34700609 — intervention group
Group type: EXPERIMENTAL
Intervention: NBTXR3 + RT
Number of subjects: 9
Study 34700609 — intervention group
Group type: EXPERIMENTAL
Intervention: NBTXR3 + RT + anti-PD-1
Number of subjects: 9
Study 34700609 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 9
Study 36368938 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised medicine management plan (MMP) plus Discharge Medical Service (DMS)
Number of subjects: 682
Study 36368938 — intervention group
Group type: COMPARATOR
Intervention: Discharge Medical Service (DMS) only
Number of subjects: 682
Study 33470681 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ocular hypertonic saline
Number of subjects: 16
Study 32668487 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 36
Study 32668487 — intervention group
Group type: COMPARATOR
Intervention: Control (non-penetrating acupuncture)
Number of subjects: 36
Study 35804037 — intervention group
Group type: COMPARATOR
Intervention: Conventional motorized treadmill (MT)
Number of subjects: 9
Study 34505215 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact intervention involving LGBT educators' 'coming-out story'
Number of subjects: 117
Study 34505215 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 117
Study 35354614 — intervention group
Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor (PF‐06865571, ervogastat) 25-300 mg BID or 150-300 mg once a day
Number of subjects: 450
Study 35354614 — intervention group
Group type: EXPERIMENTAL
Intervention: DGAT2 inhibitor (PF‐06865571, ervogastat) 150-300 mg BID + ACC inhibitor (PF‐05221304, clesacostat) 5-10 mg BID
Number of subjects: 450
Study 35354614 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 450
Study 35354614 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 450
Study 34107792 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical silicone gel only
Number of subjects: 153
Study 34107792 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure garment only
Number of subjects: 153
Study 34107792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined topical silicone gel and pressure garment
Number of subjects: 153
Study 32360852 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with a diode laser (670 nm, 150 mW, 1.1 W/cm2) and methylene blue photosensitizer (0.005% concentration) applied once at baseline.
Number of subjects: 71
Study 32360852 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with adjunctive mechanical debridement.
Number of subjects: 71
Study 33893561 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 6632
Study 33893561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6632
Study 33906601 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted technique
Number of subjects: 144
Study 33906601 — intervention group
Group type: COMPARATOR
Intervention: Conventional puncture method
Number of subjects: 144
Study 32689839 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) + Proportional Assisted Ventilation (PAV)
Number of subjects: 9
Study 32689839 — intervention group
Group type: COMPARATOR
Intervention: Proportional Assisted Ventilation (PAV)
Number of subjects: 9
Study 32689839 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 9
Study 33980046 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline penumbra
Number of subjects: 126
Study 33980046 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninfarcted penumbra at 24 hours (WAKE‐UP)
Number of subjects: 126
Study 33980046 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninfarcted penumbra at 30 days (AXIS 2)
Number of subjects: 126
Study 32363592 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (up to 2 mg/d)
Number of subjects: 47
Study 32363592 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 35770579 — intervention group
Group type: EXPERIMENTAL
Intervention: Yamamoto New Scalp Acupuncture (YNSA)
Number of subjects: 24
Study 35770579 — intervention group
Group type: COMPARATOR
Intervention: Control group (no application of acupuncture)
Number of subjects: 24
Study 35770579 — intervention group
Group type: EXPERIMENTAL
Intervention: YNSA
Number of subjects: 24
Study 35770579 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24